FDA Approved: VYVGART HYTRULO — Original Application (argenx US)

View source ↗

Summary

The FDA approved Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase, human recombinant) under an Original Application from argenx US. It introduces a subcutan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT))

Snippet

ORIG AP for VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT))